Shockwave Medical to Present at the Canaccord Genuity 40th Annual Growth Conference
July 30 2020 - 8:00AM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development of Intravascular Lithotripsy (IVL) to treat complex
calcified cardiovascular disease, announced today that it will be
participating in the Canaccord Genuity 40th Annual Growth
Conference, scheduled to be held virtually August 11 to 13, 2020.
Shockwave's management is scheduled for a live fireside chat on
Wednesday, August 12, 2020, at 2:30 p.m. Eastern Time. Interested
parties may access a live and archived webcast of the event on the
"Investors" section of the company’s website at
https://ir.shockwavemedical.com.
About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing
products intended to transform the way calcified cardiovascular
disease is treated. The company aims to establish a new standard of
care for the interventional treatment of atherosclerotic
cardiovascular disease through differentiated and proprietary local
delivery of sonic pressure waves for the treatment of calcified
plaque, which the company refers to as Intravascular Lithotripsy
(IVL). IVL is a minimally invasive, easy-to-use and safe way to
significantly improve patient outcomes. To view an animation of the
IVL procedure and for more information, visit
www.shockwavemedical.com.
Media Contact: Scott Shadiow
+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterinvestors@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Sep 2023 to Sep 2024